5001 - 5025 of 6433 Results
Title
Year
-
OPENTitle: T lymphocyte senescence is attenuated in Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12974-021-02287-9Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-021-02287-9Citation Count: 31
- Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases2021OPENTitle: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligasesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0258315End Page: e0258315Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0258315Best OA location URL: https://doi.org/10.1371/journal.pone.0258315Citation Count: 16
-
OPENTitle: Relationships between Mitochondrial Function, AMPK, and TORC1 Signaling in Lymphoblasts with Premutation Alleles of the FMR1 GeneJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 19Start Page: 10393End Page: 10393Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms221910393Best OA location URL: https://www.mdpi.com/1422-0067/22/19/10393/pdf?version=1632737629Citation Count: 4
-
OPENTitle: Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear PalsyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.736784Best OA location URL: https://escholarship.org/uc/item/4rt0n68qCitation Count: 4
-
OPENTitle: Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathwayJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 32Issue #:Start Page: 102846End Page: 102846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2021.102846Best OA location URL: https://doi.org/10.1016/j.nicl.2021.102846Citation Count: 43
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 177
-
OPENTitle: Detecting the symptoms of Parkinson’s disease with non-standard videoJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page: 72End Page: 72Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-024-01362-5Best OA location URL: https://jneuroengrehab.biomedcentral.com/counter/pdf/10.1186/s12984-024-01362-5Citation Count: 3
-
OPENTitle: Interaction of an α-synuclein epitope with HLA-DRB1∗15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s diseaseJournal Name: NeuronPublisher: Elsevier BVVol: 111Issue #: 21Start Page: 3397End Page: 3413.e5Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuron.2023.07.015Best OA location URL: http://www.cell.com/article/S0896627323005482/pdfCitation Count: 32
- Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s disease2024OPENTitle: Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 5Start Page: 1644End Page: 1652Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae061Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae061/56817302/awae061.pdfCitation Count: 4
- Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s disease2024OPENTitle: Associations of sleep disorders with serum neurofilament light chain levels in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03642-yBest OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03642-yCitation Count: 7
-
OPENTitle: O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathologyJournal Name: Nature Chemical BiologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 5Start Page: 646End Page: 655Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41589-024-01551-2Best OA location URL: https://www.nature.com/articles/s41589-024-01551-2.pdfCitation Count: 38
-
OPENTitle: Predicting the occurrence of mild cognitive impairment in Parkinson’s disease using structural MRI dataJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2024.1375395Best OA location URL: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1375395/pdfCitation Count: 3
-
OPENTitle: Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass SpectrometryJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 23Issue #: 4Start Page: 1221End Page: 1231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.3c00685Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11065482/pdf/nihms-1988478.pdfCitation Count: 2
-
OPENTitle: Structural underpinnings and long-term effects of resilience in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00699-xBest OA location URL: https://www.nature.com/articles/s41531-024-00699-x.pdfCitation Count: 2
-
OPENTitle: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 749468End Page: 749468Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.749468Best OA location URL: https://doi.org/10.3389/fimmu.2021.749468Citation Count: 19
-
OPENTitle: Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.723476Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.723476/pdfCitation Count: 7
- Cortical and subcortical functional connectivity and cognitive impairment in Parkinson’s disease2024OPENTitle: Cortical and subcortical functional connectivity and cognitive impairment in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 42Issue #:Start Page: 103610End Page: 103610Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.nicl.2024.103610Best OA location URL: https://doi.org/10.1016/j.nicl.2024.103610Citation Count: 8
-
OPENTitle: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19Journal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-024-01761-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-024-01761-8Citation Count: 2
-
OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 20
-
OPENTitle: Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian CohortsJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 10Issue #: 21Start Page: 5085End Page: 5085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm10215085Best OA location URL: https://www.mdpi.com/2077-0383/10/21/5085/pdf?version=1635753758Citation Count: 12
-
OPENTitle: Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 21Start Page: 11522End Page: 11522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms222111522Best OA location URL: https://www.mdpi.com/1422-0067/22/21/11522/pdf?version=1635236511Citation Count: 10
-
OPENTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01282-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01282-8Citation Count: 185
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 23
-
OPENTitle: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disordersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 6Start Page: 961End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02367-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02367-3.pdfCitation Count: 45